These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

263 related items for PubMed ID: 25644368

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The lymphatic system plays a major role in the intravenous and subcutaneous pharmacokinetics of trastuzumab in rats.
    Dahlberg AM, Kaminskas LM, Smith A, Nicolazzo JA, Porter CJ, Bulitta JB, McIntosh MP.
    Mol Pharm; 2014 Feb 03; 11(2):496-504. PubMed ID: 24350780
    [Abstract] [Full Text] [Related]

  • 4. PEGylation of interferon α2 improves lymphatic exposure after subcutaneous and intravenous administration and improves antitumour efficacy against lymphatic breast cancer metastases.
    Kaminskas LM, Ascher DB, McLeod VM, Herold MJ, Le CP, Sloan EK, Porter CJ.
    J Control Release; 2013 Jun 10; 168(2):200-8. PubMed ID: 23499718
    [Abstract] [Full Text] [Related]

  • 5. PEGylation of polylysine dendrimers improves absorption and lymphatic targeting following SC administration in rats.
    Kaminskas LM, Kota J, McLeod VM, Kelly BD, Karellas P, Porter CJ.
    J Control Release; 2009 Dec 03; 140(2):108-16. PubMed ID: 19686787
    [Abstract] [Full Text] [Related]

  • 6. Removal of interstitial hyaluronan with recombinant human hyaluronidase improves the systemic and lymphatic uptake of cetuximab in rats.
    Styles IK, Feeney OM, Nguyen TH, Brundel DHS, Kang DW, Clift R, McIntosh MP, Porter CJH.
    J Control Release; 2019 Dec 10; 315():85-96. PubMed ID: 31655131
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Optimal PEGylation can improve the exposure of interferon in the lungs following pulmonary administration.
    Mcleod VM, Chan LJ, Ryan GM, Porter CJ, Kaminskas LM.
    J Pharm Sci; 2015 Apr 10; 104(4):1421-30. PubMed ID: 25631360
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. PEGylated polylysine dendrimers increase lymphatic exposure to doxorubicin when compared to PEGylated liposomal and solution formulations of doxorubicin.
    Ryan GM, Kaminskas LM, Bulitta JB, McIntosh MP, Owen DJ, Porter CJH.
    J Control Release; 2013 Nov 28; 172(1):128-136. PubMed ID: 23954628
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Lymphatic Distribution of Etanercept Following Intravenous and Subcutaneous Delivery to Rats.
    Gao X, Voronin G, Generaux C, Rose A, Kozhich A, Dalglish G, Rosa R, Oh S, Kagan L.
    Pharm Res; 2020 Jul 27; 37(8):155. PubMed ID: 32720159
    [Abstract] [Full Text] [Related]

  • 20. Docetaxel Accumulates in Lymphatic Circulation Following Subcutaneous Delivery Compared to Intravenous Delivery in Rats.
    Worley DR, Hansen RJ, Wittenburg LA, Chubb LS, Gustafson DL.
    Anticancer Res; 2016 Oct 27; 36(10):5071-5078. PubMed ID: 27798866
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.